The heterogeneity in cancers documented among our patients with germline ATM variants and their families further emphasizes the value of pan-cancer panels, and certainly the importance of including ATM in multi-gene panels testing for hereditary cancer predisposition. The gene discussed is ATM; the disease is cancer.